XML 30 R18.htm IDEA: XBRL DOCUMENT

Note 11 - Stock-Based Compensation

9 Months Ended

Sep. 30, 2024

Notes to Financial Statements

Shareholders' Equity and Share-Based Payments [Text Block]

11.

Stock-Based Compensation

Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 was allocated as follows:

		Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands)		2024				2023				2024				2023
Cost of revenues		$	(30	)		$	58			$	88			$	222
Sales and marketing expenses			164				193				453				533
General and administrative expenses			795				1,012				2,493				2,585
Research and development expenses			124				100				345				278
Total stock-based compensation		$	1,053			$	1,363			$	3,379			$	3,618

As of September 30, 2024, the total compensation costs related to unvested awards not yet recognized was $5.7 million and the weighted average period over which it is expected to be recognized is approximately 1.8 years. The Company did not capitalize any stock-based compensation.

Restricted stock unit (“RSU”) activity for the nine months ended September 30, 2024 was as follows:

										Market-								Performance-
		Time-Based								Based								Based
		Restricted				Grant Date				Restricted				Grant Date				Restricted				Grant Date
		Stock Units				Fair Value				Stock Units				Fair Value				Stock Units				Fair Value
Balance at December 31, 2023			1,164,996			$	3.28				801,845			$	3.37				-			$	-
Granted			1,002,520				3.98				-				-				375,895				4.19
Vested			(150,383	)			4.95				-				-				-				-
Forfeited			(120,892	)			3.64				-				-				-				-
Balance at September 30, 2024			1,896,241			$	3.49				801,845			$	3.37				375,895			$	4.19

Unvested shares related to market-based and performance-based vesting conditions are reflected at 100% of their target vesting amount in the table above. Actual vesting could range from zero up to 150% of their target amounts.

Performance-based RSU awards are contingent on the achievement of certain performance metrics. Compensation cost associated with performance-based RSUs are recognized based on the estimated number of shares that the Company ultimately expects will be earned. If the estimated number of shares to be earned is revised in the future, then stock-based compensation expense will be adjusted accordingly.

Stock option activity for the nine months ended September 30, 2024 was as follows:

		Number of Options				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Term				Aggregate Intrinsic Value (in thousands)
Outstanding and exercisable at December 31, 2023			924,067			$	3.37
Exercised			(13,586	)			3.18
Cancelled/Forfeited			(23,766	)			4.54
Outstanding and exercisable at September 30, 2024			886,715			$	3.34				2.7			$	28

The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value, based on the Company’s closing stock price of $2.69 as of the last trading day of the reporting period, which would have been received by the option holders had all option holders exercised their options as of that date. The aggregate intrinsic value of options exercised during the nine months ended September 30, 2024, was not significant.